Shukra Pharma secures Rs 24-cr order from HSCC

The contract value of Rs 24.06 crore includes packing, forwarding, insurance, and delivery at the consignee site in Afghanistan.

Shukra Pharmaceuticals manufactures and markets pharmaceutical products and does laboratory testing.

The company reported a 110.2% surge in standalone net profit to Rs 1.03 crore, while revenue from operations rose 69.5% to Rs 5.39 crore in Q1 FY26 over Q1 FY25.

The scrip rose 1.98% to settle at Rs 25.71 on the BSE.

Powered by Capital Market - Live News